A research team developed an autologous full-thickness oral substitute that mimics the characteristics of gingiva, providing a promising solution for oral cavity reconstruction. The study's results support the need for larger clinical trials to further evaluate the effectiveness of this new tissue-engineered product.
Researchers explore alternative anatomical sites for islet transplantation, including the pancreas, to improve engraftment potential and patient safety. Bioartificial pancreas engineering and encapsulation technologies are also being developed to overcome challenges in current transplantation methods.
Researchers have successfully transplanted de-differentiated fat (DFAT) cells into animal models, promoting functional recovery and motor function after spinal cord injury. The study suggests that DFAT cells could be a source for cell replacement therapy to treat central nervous system disorders.
Researchers successfully monitored transplanted stem cells using bioluminescent imaging and iron oxide, enabling non-invasive tracking. Three different labeling methods were evaluated for their reliability in detecting transplanted mensenchymal stem cells, with DAPI labeling showing promising results.
Researchers found that direct implantation of mesenchymal stem cells did not remyelinate the damaged area, but still consider MSCs a promising tool for neurological disorders due to their pre-clinical efficacy in treating stroke and MS.
Researchers found that combining adult cardiomyocytes with bone marrow cells enhances therapeutic effects and reduces programmed cell death. The technique shows promise as a new strategy for myocardial repair, with potential applications in cardiac tissue regeneration.
Researchers found that transplantation of human cord blood cells can repair cochlear damage in animal models, with dramatic repair observed despite few human-derived cells migrating to the cochlea. The study suggests a potential treatment strategy for inner ear rehabilitation and hearing impairments caused by cochlear damage.
Researchers at the University of Florida have identified a molecular signature based on gene expression that can predict the development of acute graft-versus-host disease (GVHD) in patients receiving liver stem cell transplants. This could lead to better biomarkers for determining patient risk and improving treatment outcomes.
Researchers have made significant progress in developing neural cell transplants as a potential treatment for Parkinson's disease. Engineered human neural progenitor cells that produce glial-derived neurotrophic factor (GDNF) show promise in promoting functional recovery and improving motor function without causing negative side effects.
The American Society for Neural Therapy and Repair (ASNTR) has awarded neuroscientist Paul M. Carvey for his groundbreaking research on Parkinson's Disease, while recognizing patient advocate Joan Samuelson for her tireless advocacy efforts.
Researchers have identified menstrual blood as a valuable source of multipotential stem cells, which can differentiate into various cell lineages. The study found that these cells exhibit self-renewal and multipotency properties, making them suitable for regenerative transplantation therapies.
Researchers are exploring stem cell transplants to provide insulin cells for a bioartificial pancreas, addressing the shortage of human pancreatic islet tissue. They also aim to target and destroy cancer stem cells to improve therapies and develop reversible immortalized cell lines.
A dietary supplement containing blueberry, green tea, vitamin D3, and carnosine extracts has been shown to reduce neural damage and motor deficits in animal models after a simulated stroke. The study found that the supplement increased new neuron production and was 100 times more potent than individual ingredients.
Researchers found that human mesenchymal stem cells (hMSCs) and bone marrow stromal cells (BMSCs) can migrate to damaged brain tissue after a stroke, improving neural function. The transplanted cells may also enhance tissue repair and functional recovery.
Researchers have made significant progress in cardiac stem cell therapy, exploring novel delivery methods and strategies to improve cell survival. These advancements aim to overcome the challenges of poor vascular supply and inflammation after a heart attack, paving the way for more effective treatments.
Researchers at Kyoto University School of Medicine successfully regenerated damaged nerves using bone marrow cells containing adult stem cells. The transplanted cells differentiated into Schwann cells, promoting axon regeneration and healthier vascularity.
Researchers found that skeletal myoblasts can help improve urinary incontinence in female rats with urethral sphincter deficiency when transplanted into their nerve-damaged muscles. The transplanted muscle cells increased urethral pressure, leading to significant improvement in incontinence and near-normal urethral closure pressures.